Business · 18/09/2018Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Endocrinologic and Metabolic Drugs Advisory Committee
Summary
The FDA is hosting a public meeting of its Endocrinologic and Metabolic Drugs Advisory Committee to gather input on regulatory issues, and is seeking public comments on the matter, with the meeting to be open to the public.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →